PreprintAll rights reservedbioRxiv
Development of a nanomedicine approach to improve the therapeutic index of bexarotene.
- 1Cardiff University
Related
- Chitosan nanoparticles functionalised with protocatechuic acid improve colon-targeted pazopanib delivery with multi-pathway therapeutic regulation and pharmacokinetic optimisation in colorectal cancer
- Cholesterol-Mediated Modulation of Collecting Lymphatic Vessel Contractility: Exploring Cholesterol Depletion as a Therapeutic Alternative to Improve Lymphatic Function in Hypercholesterolemia
- From digital reminders to artificial intelligence–enabled understanding: can personalized treatment predictions improve therapeutic adherence?
- Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
- Culturally adapted home-based intervention to improve child’s development in Arab toddlers in Israel: study protocol for a randomized controlled trial
BibTeX
@misc{rizzo2026development,
title = {{Development of a nanomedicine approach to improve the therapeutic index of bexarotene.}},
author = {S. Rizzo and C. Pepe and T. Albert and G. Braux and T. Cahart and C. Varicchio and T. Robertshaw and T. R. Hughes and Y. Zhou and E. L. Ferguson},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.05.756654},
url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756654v1},
}
RIS
TY - UNPB
TI - Development of a nanomedicine approach to improve the therapeutic index of bexarotene.
AU - S. Rizzo
AU - C. Pepe
AU - T. Albert
AU - G. Braux
AU - T. Cahart
AU - C. Varicchio
AU - T. Robertshaw
AU - T. R. Hughes
AU - Y. Zhou
AU - E. L. Ferguson
PY - 2026
DA - 2026/10/05
PB - bioRxiv
DO - 10.64898/2026.10.05.756654
UR - https://www.biorxiv.org/content/10.64898/2026.10.05.756654v1
ER -